x

Search for a clinical trial

* (*) mandatory field

An Open-Label Study for Previously Treated Ataluren (PTC124) Patients With Nonsense Mutation Dystrophinopathy (Phase III) - ES

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : No
  • Status : Terminated trial
  • Funding body(ies) :
  • Geographic coverage : Global
  • Sponsor : Ptc therapeutics, inc.
    • Phase : III
  • Principal investigator of clinical trial

  • Dr Jaume COLOMER OFERIL
  • Servicio de Neurología
  • Hospital Sant Joan de Déu Barcelona
  • Paseo de Sant Joan de Déu, 2
  • 08950 ESPLUGUES DE LLOBREGAT
  • SPAIN
  • More information
  • Phone  : 34 93 253 21 00
  • Fax  : -
  • Website
Last update: April 2018

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.